SAN

77.5

-0.64%↓

UCB

245.7

-2.15%↓

SHL.DE

36.54

-1.67%↓

ARGX

586.2

-0.71%↓

VIE

31.08

-1.8%↓

SAN

77.5

-0.64%↓

UCB

245.7

-2.15%↓

SHL.DE

36.54

-1.67%↓

ARGX

586.2

-0.71%↓

VIE

31.08

-1.8%↓

SAN

77.5

-0.64%↓

UCB

245.7

-2.15%↓

SHL.DE

36.54

-1.67%↓

ARGX

586.2

-0.71%↓

VIE

31.08

-1.8%↓

SAN

77.5

-0.64%↓

UCB

245.7

-2.15%↓

SHL.DE

36.54

-1.67%↓

ARGX

586.2

-0.71%↓

VIE

31.08

-1.8%↓

SAN

77.5

-0.64%↓

UCB

245.7

-2.15%↓

SHL.DE

36.54

-1.67%↓

ARGX

586.2

-0.71%↓

VIE

31.08

-1.8%↓

Home・Akcijų sąrašas・Nanobiotix

N
Nanobiotix

Uždarymo kaina

25.65 -5.7

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

25.45

Max

27.75

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-5.4M
Pardavimai	27M
Pelno marža	-20.208
Darbuotojai	103
EBITDA	1.1M

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	-16.06% downside

Dividendai
By Dow Jones
Kitas uždarbis	2026-04-01

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	1.4B
Ankstesnė atidarymo kaina	31.35
Ankstesnė uždarymo kaina	25.65

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bullish Evidence

2.975 / 3.015 Palaikymas ir pasipriešinimas

Nanobiotix Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-20 17:19; UTC

Svarbiausios naujienos

Chubb to Assume Risk, Issue Policies for $20 Billion Strait of Hormuz Insurance Facility

2026-03-20 16:56; UTC

Svarbiausios naujienos

Week Ahead for FX, Bonds: PMI Data to Show Middle East War's Impact on Sentiment

2026-03-20 16:56; UTC

Svarbiausios naujienos

Week Ahead for FX, Bonds: PMI Data to Show Middle -2-

2026-03-20 16:45; UTC

Svarbiausios naujienos

The Week in Oil: U.S. Seeks to Ease Concerns Over War But Supply Risks Mount

2026-03-20 16:22; UTC

Svarbiausios naujienos

NYMEX Overview: Petroleum Futures Rise, Leaving Most Contracts on Track for Solid Weekly Gains -- OPIS

2026-03-20 20:50; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Basic Materials Roundup: Market Talk

2026-03-20 20:50; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Health Care Roundup: Market Talk

2026-03-20 19:55; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Brent Crude Closes Out Volatile Week Higher -- Market Talk

2026-03-20 19:28; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Natural Gas Falls as Traders Sell Ahead of the Weekend -- Market Talk

2026-03-20 19:28; UTC

Įsigijimai, susijungimai, perėmimai

Ecolab Buys CoolIT Systems for $4.75 Billion. It's All About AI for the Struggling Stock. -- Barrons.com

2026-03-20 18:39; UTC

Rinkos pokalbiai

Gold Settles With Largest Weekly Dollar Decline on Record -- Market Talk

2026-03-20 18:31; UTC

Įsigijimai, susijungimai, perėmimai

Honeywell Announces Pricing of Debt Tender Offers >HON

2026-03-20 18:19; UTC

Įsigijimai, susijungimai, perėmimai

Why Mayo and Soap No Longer Mix for Unilever -- Update

2026-03-20 18:15; UTC

Rinkos pokalbiai

iMarkets May Be Wrong in Pricing for Canadian Rate Increases -- Market Talk

2026-03-20 17:57; UTC

Rinkos pokalbiai

U.S. Oil Rig Count Inches Up -- Market Talk

2026-03-20 17:04; UTC

Svarbiausios naujienos

Chubb to Assume Risk, Issue Policies for $20B Strait of Hormuz Insurance Facility

2026-03-20 16:20; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Basic Materials Roundup: Market Talk

2026-03-20 16:20; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Health Care Roundup: Market Talk

2026-03-20 15:40; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Unilever, McCormick Deal Makes Strategic Sense, But Risk Remains -- Market Talk

2026-03-20 15:30; UTC

Uždarbis

Gemini Space Station's Earnings 'Better Than Feared.' Can They Save the Stock? -- Barrons.com

2026-03-20 15:26; UTC

Rinkos pokalbiai

Uždarbis

Svarbiausios naujienos

Lands' End: War Impacts Weighing on Some European Consumers -- Market Talk

2026-03-20 15:26; UTC

Įsigijimai, susijungimai, perėmimai

Why Mayo and Soap No Longer Mix for Unilever -- WSJ

2026-03-20 15:25; UTC

Rinkos pokalbiai

Gilt Selloff Shows Vulnerability of U.K.'s Economy -- Market Talk

2026-03-20 15:19; UTC

Rinkos pokalbiai

Svarbiausios naujienos

UBS Raises Oil Price Forecast as Middle East Conflict Escalates -- Market Talk

2026-03-20 14:58; UTC

Svarbiausios naujienos

Chevron Jumps Into Top 20 Most Valuable U.S. Companies. The Iran War's Other Big Stock Movers. -- Barrons.com

2026-03-20 14:55; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Gold Lower as Speculative Pullback Extends -- Market Talk

2026-03-20 14:54; UTC

Įsigijimai, susijungimai, perėmimai

Ecolab Buys CoolIT Systems for $4.75 Billion. It's All About AI for the Struggling Stock. -- Barrons.com

2026-03-20 14:53; UTC

Įsigijimai, susijungimai, perėmimai

Unilever, McCormick Deal Would Create a New Condiment King -- WSJ

2026-03-20 14:46; UTC

Rinkos pokalbiai

U.K. Government Bonds Selloff More Pronounced Than Peers -- Market Talk

2026-03-20 14:45; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Oil Price Forecasts For 2026-27 Raised at UBS -- Market Talk

Akcijų palyginimas

Kainos pokytis

Nanobiotix Prognozė

Kainos tikslas

By TipRanks

-16.06% į apačią

12 mėnesių prognozė

Vidutinis 23 EUR -16.06%

Aukščiausias 23 EUR

Žemiausias 23 EUR

Remiantis 1 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Nanobiotix kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

1 ratings

Pirkti

Laikyti

Parduoti

Remiantis 1 analitikų, pateikusių Nanobiotix akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

2.975 / 3.015Palaikymas ir pasipriešinimas

Recent bullish events outweigh bearish events.

Bearish events outweigh bullish events.

There is one bearish event.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Nanobiotix

Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is headquartered in Paris, France.